The Wyss Institute at Harvard University will use its organs-on-chips technology to evaluate medical countermeasures against acute radiation syndrome, or ARS, under a $5.6 million grant from the FDA. As part of the contract, scientists at Wyss will test possible countermeasures for ARS on models of radiation damage in bone marrow, gut and lung organs-on-chips.
FDA backs development of radiation-sickness countermeasures
SmartBrief Job Listings for Health Care
|Account Management and Product Development Specialist||
Sharp Health Plan
|San Diego, CA|
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.